Clinical Trial Update: Vortioxetine for the Treatment of Hoarding Disorder [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vortioxetine for hoarding disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hoarding Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Noam Soreni | Conditions: Hoarding Disorder | Phase 3 | Status: WITHDRAWN